Image 1 of 1
Image 1 of 1
Image 1 of 1
Image 1 of 1
XOCOVA (ensitrelvir) is a prescription oral antiviral medication approved by the U.S. Food and Drug Administration (FDA) to help prevent symptomatic COVID-19 in adults and children aged 12 years and older after they have been exposed to someone with the virus. It is the first and only oral pill approved for this specific use, known as post-exposure prophylaxis (PEP).
XOCOVA (ensitrelvir) is a prescription oral antiviral medication approved by the U.S. Food and Drug Administration (FDA) to help prevent symptomatic COVID-19 in adults and children aged 12 years and older after they have been exposed to someone with the virus. It is the first and only oral pill approved for this specific use, known as post-exposure prophylaxis (PEP).